Skip to main content

Progestin-Only Oral Contraceptives

  • Chapter
The Handbook of Contraception

Abstract

Progestin-only pills (POPs) are often referred to as “mini-pills” as they contain about 75 % of the progestin dose contained in combination oral contraceptives (COCs) and no estrogen. Their typical effectiveness has been shown to be slightly less than COCs; most likely due to a more limited duration of effect and inconsistent ovulation suppression. POPs are associated with more breakthrough bleeding than COCs but fewer serious adverse events. Although not as well studied, POPs are thought to have many of the same non-contraceptive health benefits as COCs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. CDC. U.S. Medical eligibility criteria for contraceptive use. 2010. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5904a1.htm?s_cid=rr5904a1_e. Accessed 31 May 2014.

  2. CDC. U.S. selected practice recommendations for contraceptive use. 2013. http://www.cdc.gov/mmwr/pdf/rr/rr62e0614.pdf. Accessed 31 May 2014.

  3. Edelman AB, Cherala G, Stanczyk FZ. Metabolism and pharmacokinetics of contraceptive steroids in obese women: a review. Contraception. 2010;82(4):314–23. doi:10.1016/j.contraception.2010.04.016.

    Article  CAS  PubMed  Google Scholar 

  4. Medline Plus. Progestin-only oral contraception. 2010. www.nlm.nih.gov/medlineplus/druginfo/meds/a602008.html. Accessed 24 Apr 2014.

  5. Moghissi KS, Marks C. Effects of microdose norgestrel on endogenous gonadotropic and steroid hormones, cervical mucus properties, vaginal cytology, and endometrium. Fertil Steril. 1971;22(7):424–34.

    CAS  PubMed  Google Scholar 

  6. Rice CF, Killick SR, Dieben T, Coelingh Bennink H. A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily. Hum Reprod. 1999;14(4):982–5.

    Article  CAS  PubMed  Google Scholar 

  7. Speroff L, Darney P. A clinical guide for contraception. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2011.

    Google Scholar 

  8. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83(5):397–404.

    Article  PubMed Central  PubMed  Google Scholar 

  9. WHO. Selected practice recommendations for contraceptive use. WHO. 2004. http://whqlibdoc.who.int/publications/2004/9241562846.pdf. Accessed 31 May 2014.

  10. WHO. Medical eligibility criteria for contraceptive use. 2009. http://www.who.int/eproductivehealth/publications/family_planning/9789241563888/en/. Accessed 02 Jan 2010.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Regina-Maria Renner MD, MPH, FRCSC, FACOG .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Renner, RM., Edelman, A. (2016). Progestin-Only Oral Contraceptives. In: Shoupe, D., Mishell, Jr., D. (eds) The Handbook of Contraception. Current Clinical Practice. Humana Press, Cham. https://doi.org/10.1007/978-3-319-20185-6_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-20185-6_5

  • Publisher Name: Humana Press, Cham

  • Print ISBN: 978-3-319-20184-9

  • Online ISBN: 978-3-319-20185-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics